Wall Street’s Super Bowl Wednesday: Alphabet, Amazon, Microsoft and Meta report along with Powell’s last Fed meetingApril 26, 2026
Stocks This biotech is working on a GLP-1 pill that could be better than the Wegovy versionBy AdminMarch 17, 2026 This experimental pill helped people lose about 16% of their body weight after about a year of treatment
Stocks Hims & Hers stock poised for heavy losses after quick U-turn on plan for oral Wegovy competitorBy AdminFebruary 9, 2026 Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its…
Stocks Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.By AdminJune 24, 2025 Hims & Hers Health’s stock booked record losses Monday after Novo Nordisk, maker of the weight-loss drug Wegovy, said it…
